Angiodynamics, Inc. (NASDAQ: ANGO) reported Q4 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $57.7 million versus the consensus estimate of $52.97 million.

Sees FY2013 EPS of $0.49-$0.51, versus the consensus of $0.48. Angiodynamics, Inc. sees FY2013 revenue of $360-$363 million, versus the consensus of $356.7 million.

For earnings history and earnings-related data on Angiodynamics, Inc. (ANGO) click here.

Earnings Guidance